| Jessica Croteau, PA | |
|
100 Robie Road, Bristol, NH 03222 | |
| (603) 744-6200 | |
| (603) 536-4001 |
| Full Name | Jessica Croteau |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 9 Years |
| Location | 100 Robie Road, Bristol, New Hampshire |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356724843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 1107 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Speare Memorial Hospital | Plymouth, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-state Health Center | 1951363563 | 33 |
News Archive
A new study published in the journal Nature Communications describes a breakthrough in research related to facioscapulohumeral muscular dystrophy (FSHD). The debilitating genetic disease - which has no approved treatment - affects an estimated 38,000 Americans and causes degeneration and wasting of the skeletal muscles.
A national research trial initiated by UT Southwestern in 2012 is generating the first set of results this year that provides an early glimpse into how such high-tech strategies may change the field of mental health.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71, which causes hand, foot, and mouth disease.
Physical activity requires strong, healthy muscles. Fortunately, when people exercise on a regular basis, their muscles experience a continuous cycle of muscle breakdown (during exercise) and compensatory remodeling and growth. Athletes have long experimented with methods to augment these physiologic responses to enhance muscle growth.
Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Croteau, PA 14 Arlington St, Laconia, NH 03246-2002 Ph: (603) 219-1335 | Jessica Croteau, PA 100 Robie Road, Bristol, NH 03222 Ph: (603) 744-6200 |
News Archive
A new study published in the journal Nature Communications describes a breakthrough in research related to facioscapulohumeral muscular dystrophy (FSHD). The debilitating genetic disease - which has no approved treatment - affects an estimated 38,000 Americans and causes degeneration and wasting of the skeletal muscles.
A national research trial initiated by UT Southwestern in 2012 is generating the first set of results this year that provides an early glimpse into how such high-tech strategies may change the field of mental health.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71, which causes hand, foot, and mouth disease.
Physical activity requires strong, healthy muscles. Fortunately, when people exercise on a regular basis, their muscles experience a continuous cycle of muscle breakdown (during exercise) and compensatory remodeling and growth. Athletes have long experimented with methods to augment these physiologic responses to enhance muscle growth.
Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed.
› Verified 8 days ago